Phosphonoacetic acid
Based on 3 publication(s) in Google Scholar
Phosphonoacetic acid is an endogenous metabolite and antiviral agent. Phosphonoacetic acid is active against orthopoxviruses and herpes viruses. Phosphonoacetic acid can inhibit HSV DNA synthesis and virus-specific DNA polymerase activity, and affect the synthesis of late viral proteins.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit: 98.0%
- CAS. Nr.: 4408-78-0
- Formel: C2H5O5P
- Molecular Weight:140.03
-
Speicherung:
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
-
Lösungsmittel & Löslichkeit
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
-
Microbial Metabolite Library
HY-L084
-
Food-Sourced Compound Library
HY-L094
-
Human Metabolite Library
HY-L123
-
Anti-Orthopoxvirus Compound Library
HY-L127
-
Animal-Sourced Natural Product Library
HY-L157
-
Highly Selective Inhibitors Library
HY-L158
-
Multi-Target Compound Library
HY-L176
-
Bioactive Compound Library Max
HY-L181
-
MCE Bioactive Compound Library
HY-L001V
-
Natural Product Library Plus
HY-L021P
-
Bioactive Compound Library
HY-L001
-
RO5 Drug-like Natural Product Library
HY-L200
-
High-Throughput Bioactive Compound Library
HY-L205
-
High-Throughput Natural Product Library
HY-L206
-
Amino Acid Metabolite Compound Library
HY-L227
-
Natural Product Diversity Scaffold Library
HY-L245
-
Natural Product and Natural Product-Like Compound Library
HY-L021M
-
Anti-Infection Compound Library
HY-L002
-
Cell Cycle/DNA Damage Compound Library
HY-L004
-
Metabolism/Protease Compound Library
HY-L012
-
Natural Product Library
HY-L021
-
Antiviral Compound Library
HY-L027
-
Human Endogenous Metabolite Compound Library
HY-L030
-
Anti-Aging Compound Library
HY-L034
Publications Citing Use of MedChemExpress (MCE) Phosphonoacetic acid
MoreAlle Endogenous Metabolite Isoform-spezifische Produkte anzeigen
MoreAlle DNA/RNA Synthesis Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
|
DNA Polymerase |
Human Endogenous Metabolite |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Vero | CC50 |
3500 μM
Compound: Phosphonoacetic acid (PAA)
|
In vitro cytotoxic concentration in vero cells.
In vitro cytotoxic concentration in vero cells.
|
[PMID: 14584951] |
| Vero | ED50 |
240 μM
Compound: Phosphonoacetic acid (PAA)
|
Inhibitory activity against HSV-1 in vero cells
Inhibitory activity against HSV-1 in vero cells
|
[PMID: 14584951] |
Phosphonoacetic acid (≥200 μg/mL; 24 h) inhibits viral growth and DNA synthesis in HSV-1-infected BHK-21 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS. Nr. 4408-78-0
-
Appearance Solid
-
Molecular Weight 140.03
-
Formel C2H5O5P
-
Color White to off-white
-
SMILES
O=C(O)CP(O)(O)=O
-
Structure Classification
-
Initial Source
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications (3)
-
Journal Impact Factor
-
Most Recent
-
PLoS Pathog
Anti-orthopoxvirus drugs inhibit lumpy skin disease virus replication by targeting viral DNA polymerase. [Abstract]2026 Jan 26;22(1):e1013903. PMID: 41587213 -
Microbiol Spectr
2026 Jun 2;14(6):e0160825. PMID: 41995456 -
J Virol
Pseudorabies virus infection triggers mitophagy to dampen the interferon response and promote viral replication. [Abstract]2024 Oct 22;98(10):e0104824. PMID: 39212384
Lösungsmittel & Löslichkeit
H2O : 260 mg/mL (1856.74 mM; Need ultrasonic)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
For the following dissolution methods, please prepare the working solution directly:
It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: PBS
Solubility: 100 mg/mL (714.13 mM); Clear solution; Need ultrasonic
Reinheit & Dokumentation
-
Data Sheet (273 KB)
-
SDS (477 KB)
- English - EN (477 KB)
- Français - FR (477 KB)
- Deutsch - DE (477 KB)
- Norwegian - NO (477 KB)
- Español - ES (477 KB)
- Swedish - SV (477 KB)
- Italian - IT (477 KB)
- Korean - KR (477 KB)
- Portuguese - PT (477 KB)
-
Handling Instructions (2659 KB)
Verweise
[1]. Honess RW, et al. Herpes simplex virus resistance and sensitivity to phosphonoacetic acid. J Virol. 1977 Feb;21(2):584-600. [Content Brief]
[2]. Donald F Smee, et al. A review of compounds exhibiting anti-orthopoxvirus activity in animal models. Antiviral Res. 2003 Jan;57(1-2):41-52. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| H2O | 1 mM | 7.1413 mL | 35.7066 mL | 71.4133 mL | 178.5332 mL |
| 5 mM | 1.4283 mL | 7.1413 mL | 14.2827 mL | 35.7066 mL | |
| 10 mM | 0.7141 mL | 3.5707 mL | 7.1413 mL | 17.8533 mL | |
| 15 mM | 0.4761 mL | 2.3804 mL | 4.7609 mL | 11.9022 mL | |
| 20 mM | 0.3571 mL | 1.7853 mL | 3.5707 mL | 8.9267 mL | |
| 25 mM | 0.2857 mL | 1.4283 mL | 2.8565 mL | 7.1413 mL | |
| 30 mM | 0.2380 mL | 1.1902 mL | 2.3804 mL | 5.9511 mL | |
| 40 mM | 0.1785 mL | 0.8927 mL | 1.7853 mL | 4.4633 mL | |
| 50 mM | 0.1428 mL | 0.7141 mL | 1.4283 mL | 3.5707 mL | |
| 60 mM | 0.1190 mL | 0.5951 mL | 1.1902 mL | 2.9756 mL | |
| 80 mM | 0.0893 mL | 0.4463 mL | 0.8927 mL | 2.2317 mL | |
| 100 mM | 0.0714 mL | 0.3571 mL | 0.7141 mL | 1.7853 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Phosphonoacetic acid Related Classifications
HY-128744 Related Classifications
Powered by Bioz